+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Opioids"

Chronic Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pain- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Nociceptin Receptor Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Nociceptin Receptor Agonists - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Opioid Withdrawal Syndrome- - Pipeline Insight, 2025 - Product Thumbnail Image

Opioid Withdrawal Syndrome- - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Advanced Cancer Pain Management - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Cancer Pain Management - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Inflammatory Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Inflammatory Pain- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 84 Pages
  • Global
From
From
From
Intravenous Ibuprofen - Global Strategic Business Report - Product Thumbnail Image

Intravenous Ibuprofen - Global Strategic Business Report

  • Report
  • September 2025
  • 470 Pages
  • Global
From
Oxycodone Hydrochloride - Global Strategic Business Report - Product Thumbnail Image

Oxycodone Hydrochloride - Global Strategic Business Report

  • Report
  • September 2025
  • 361 Pages
  • Global
From
Pregabalin - Global Strategic Business Report - Product Thumbnail Image

Pregabalin - Global Strategic Business Report

  • Report
  • September 2025
  • 372 Pages
  • Global
From
Neuropathic Pain - Global Strategic Business Report - Product Thumbnail Image

Neuropathic Pain - Global Strategic Business Report

  • Report
  • September 2025
  • 386 Pages
  • Global
From
Over-the-Counter Pain Medication - Global Strategic Business Report - Product Thumbnail Image

Over-the-Counter Pain Medication - Global Strategic Business Report

  • Report
  • September 2025
  • 483 Pages
  • Global
From
Cancer Pain Management - Global Strategic Business Report - Product Thumbnail Image

Cancer Pain Management - Global Strategic Business Report

  • Report
  • September 2025
  • 588 Pages
  • Global
From
Topical Pain Relief - Global Strategic Business Report - Product Thumbnail Image

Topical Pain Relief - Global Strategic Business Report

  • Report
  • September 2025
  • 380 Pages
  • Global
From
Addiction Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Addiction Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 281 Pages
  • Global
From
Demerol Meperdine - Global Strategic Business Report - Product Thumbnail Image

Demerol Meperdine - Global Strategic Business Report

  • Report
  • September 2025
  • 287 Pages
  • Global
From
Paracetamol IV - Global Strategic Business Report - Product Thumbnail Image

Paracetamol IV - Global Strategic Business Report

  • Report
  • September 2025
  • 374 Pages
  • Global
From
From
Loading Indicator

Analgesics are a class of drugs used to relieve pain. Opioids are a type of analgesic that act on the nervous system to reduce the intensity of pain signals sent to the brain. Opioids are typically prescribed for moderate to severe pain, and are often used to treat chronic pain. They can be taken orally, injected, or applied topically. Opioids can be highly addictive and have a high potential for abuse, so they are typically prescribed with caution. Opioids are a major component of the analgesic market, and are used to treat a variety of conditions. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and codeine. Other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are also used to treat pain. Companies in the opioids market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more